These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-κB activation. Tian Y; Li H; Qiu T; Dai J; Zhang Y; Chen J; Cai H Aging Cell; 2019 Feb; 18(1):e12858. PubMed ID: 30548445 [TBL] [Abstract][Full Text] [Related]
4. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis. Tang X; Peng R; Phillips JE; Deguzman J; Ren Y; Apparsundaram S; Luo Q; Bauer CM; Fuentes ME; DeMartino JA; Tyagi G; Garrido R; Hogaboam CM; Denton CP; Holmes AM; Kitson C; Stevenson CS; Budd DC Am J Pathol; 2013 Aug; 183(2):470-9. PubMed ID: 23759512 [TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice. Shivshankar P; Brampton C; Miyasato S; Kasper M; Thannickal VJ; Le Saux CJ Am J Respir Cell Mol Biol; 2012 Jul; 47(1):28-36. PubMed ID: 22362388 [TBL] [Abstract][Full Text] [Related]
6. A novel senolytic drug for pulmonary fibrosis: BTSA1 targets apoptosis of senescent myofibroblasts by activating BAX. Shen M; Fu J; Zhang Y; Chang Y; Li X; Cheng H; Qiu Y; Shao M; Han Y; Zhou Y; Luo Z Aging Cell; 2024 Sep; 23(9):e14229. PubMed ID: 38831635 [TBL] [Abstract][Full Text] [Related]
7. [Protective effect of intervention with cannabinoid type-2 receptor agonist JWH133 on pulmonary fibrosis in mice]. Wu X; Yang WT; Cheng YJ; Pan L; Zhang YQ; Zhu HL; Zhang ML Zhonghua Nei Ke Za Zhi; 2023 Jul; 62(7):841-849. PubMed ID: 37394854 [No Abstract] [Full Text] [Related]
8. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L442-52. PubMed ID: 20562227 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice. Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204 [TBL] [Abstract][Full Text] [Related]
18. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis. Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656 [TBL] [Abstract][Full Text] [Related]
19. Cell senescence and fibrotic lung diseases. Liu RM; Liu G Exp Gerontol; 2020 Apr; 132():110836. PubMed ID: 31958492 [TBL] [Abstract][Full Text] [Related]
20. Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis Lehmann M; Korfei M; Mutze K; Klee S; Skronska-Wasek W; Alsafadi HN; Ota C; Costa R; Schiller HB; Lindner M; Wagner DE; Günther A; Königshoff M Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]